Bruker BRKR Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Bruker in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Bruker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bruker's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bruker's total liabilities & equity?
- Bruker (BRKR) reported total liabilities & equity of $6.13B in Q1 2026.
- How has Bruker's total liabilities & equity changed year-over-year?
- Bruker's total liabilities & equity increased by 3.3% year-over-year, from $5.93B to $6.13B.
- What is the long-term trend for Bruker's total liabilities & equity?
- Over 5 years (2020 to 2025), Bruker's total liabilities & equity has grown at a 15.4% compound annual growth rate (CAGR), from $3.05B to $6.24B.
- What does total liabilities & equity mean?
- The total value of all money owed to creditors plus the total value of shareholders' equity.
- How do you interpret total liabilities & equity?
- An increase indicates growth in the company's asset base funded by either debt or equity, while a decrease suggests a reduction in the overall scale of operations or capital structure.
- How does total liabilities & equity compare across companies?
- This is a standard accounting identity across all public companies, making it directly comparable to any peer in the life sciences or manufacturing sectors.